deoxyglucose has been researched along with Osteogenic Sarcoma in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (18.75) | 18.7374 |
| 1990's | 4 (25.00) | 18.2507 |
| 2000's | 3 (18.75) | 29.6817 |
| 2010's | 4 (25.00) | 24.3611 |
| 2020's | 2 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, MH; Chiang, CS; Hou, KT; Liu, TY; Tung, FI; Zheng, LJ | 1 |
| Ishibashi, Y; Ogawa, T; Ohshika, S; Ono, K; Sasaki, A; Yamada, K | 1 |
| Fujihara, Y; Fukunishi, S; Kato-Kogoe, N; Nakasho, K; Nishiura, H; Okamura, H; Terada, N; Yamada, N; Yamanegi, K | 1 |
| Issaq, SH; Monks, A; Teicher, BA | 1 |
| Arrabal, PM; Cifuentes, M; Domínguez, D; García, MA; Jara, N; Martínez, F; Medina, RA; Nualart, F; Weil, B; Yañez, MJ | 1 |
| Lori, JC; Rose, BJ; Sottnik, JL; Thamm, DH | 1 |
| Krishan, A; Lampidis, TJ; Maher, JC | 1 |
| Braunschweiger, P; De Young, LR; Hamilton, K; Lampidis, TJ; Maschek, G; Priebe, W; Savaraj, N; Tidmarsh, GF | 1 |
| Ahonen, A; Illukka, T; Johansson, R; Kiuru, A; Nordman, E; Paul, R; Roeda, D; Söderström, KO; Solin, O; Talvio, T | 1 |
| Bramwell, ME; Harris, H; White, MK | 1 |
| Best, JD; Bringhurst, FR; Ng, KW; Pasquini, GM; Rogers, SD; Sleeman, MW; Thomas, DM; Zajac, JD | 1 |
| Khademazad, M; Muallem, S; Whisenant, N | 1 |
| Altmann, A; Haberkorn, U; Kaick, GV; Klenner, T; Oberdorfer, F; Stöhr, M; Strauss, LG; Wallich, R | 1 |
| Hu, YP; Lampidis, TJ; Liu, H; Priebe, W; Savaraj, N | 1 |
| Loessberg, PA; Muallem, S; Star, RA; Zhang, BX | 1 |
| Levy, JR; Manolagas, S; Murray, E; Olefsky, JM | 1 |
16 other study(ies) available for deoxyglucose and Osteogenic Sarcoma
| Article | Year |
|---|---|
One-stop radiotherapeutic targeting of primary and distant osteosarcoma to inhibit cancer progression and metastasis using 2DG-grafted graphene quantum dots.
Topics: Animals; Cell Line, Tumor; Cell Movement; Cell Survival; Deoxyglucose; DNA Damage; Drug Delivery Systems; Glucose; Graphite; Humans; Mice; Neoplasm Metastasis; Osteosarcoma; Quantum Dots; Radiation-Sensitizing Agents; Reactive Oxygen Species; Treatment Outcome | 2020 |
Uptake of fluorescent D- and L-glucose analogues, 2-NBDG and 2-NBDLG, into human osteosarcoma U2OS cells in a phloretin-inhibitable manner.
Topics: 4-Chloro-7-nitrobenzofurazan; Animals; Bone Neoplasms; Cytochalasin B; Deoxyglucose; Depression, Chemical; Glucose; Glucose Transport Proteins, Facilitative; Humans; Insulinoma; Isomerism; Mice; Osteosarcoma; Pancreatic Neoplasms; Phloretin; Sodium-Glucose Transporter 2 Inhibitors; Tumor Cells, Cultured | 2021 |
Inhibition of Asparagine-linked Glycosylation Participates in Hypoxia-induced Down-regulation of Cell-surface MICA Expression.
Topics: Amino Acid Sequence; Asparagine; Cell Hypoxia; Cell Line, Tumor; Cell Membrane; Deoxyglucose; Down-Regulation; Gene Expression Regulation, Neoplastic; Glycosylation; Histocompatibility Antigens Class I; Humans; Osteosarcoma | 2018 |
Bioenergetic properties of human sarcoma cells help define sensitivity to metabolic inhibitors.
Topics: Bone Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Respiration; Deoxyglucose; Electron Transport Complex I; Energy Metabolism; Glycolysis; Humans; Hypoglycemic Agents; Metformin; Mitochondria; Mitochondrial Proton-Translocating ATPases; Oligomycins; Osteosarcoma | 2014 |
Insulin regulates GLUT1-mediated glucose transport in MG-63 human osteosarcoma cells.
Topics: Biological Transport; Blotting, Western; Cell Line, Tumor; Child; Deoxyglucose; Gene Expression Regulation, Neoplastic; Glucose; Glucose Transporter Type 1; Humans; Immunohistochemistry; Insulin; Kinetics; Neoplasm Metastasis; Osteosarcoma; Protein Isoforms; RNA, Messenger | 2011 |
Glycolysis inhibition by 2-deoxy-D-glucose reverts the metastatic phenotype in vitro and in vivo.
Topics: Animals; Antimetabolites; Blotting, Western; Bone Neoplasms; Cathepsin L; Cell Adhesion; Cell Movement; Cell Proliferation; Deoxyglucose; Dogs; Female; Fluorescent Antibody Technique; Glycolysis; Humans; In Vitro Techniques; Mice; Mice, Inbred C3H; Osteosarcoma; Oxidative Phosphorylation; Oxygen Consumption; Phenotype; Survival Rate; Tumor Cells, Cultured | 2011 |
Greater cell cycle inhibition and cytotoxicity induced by 2-deoxy-D-glucose in tumor cells treated under hypoxic vs aerobic conditions.
Topics: Aerobiosis; Antimetabolites, Antineoplastic; Bone Neoplasms; Cell Count; Cell Cycle; Cell Death; Cell Hypoxia; Coloring Agents; Deoxyglucose; DNA, Neoplasm; Flow Cytometry; Humans; Osteosarcoma; Trypan Blue | 2004 |
2-deoxy-D-glucose increases the efficacy of adriamycin and paclitaxel in human osteosarcoma and non-small cell lung cancers in vivo.
Topics: Animals; Bone Neoplasms; Carcinoma, Non-Small-Cell Lung; Deoxyglucose; Doxorubicin; Drug Synergism; Humans; Lung Neoplasms; Mice; Mice, Nude; Osteosarcoma; Paclitaxel; Transplantation, Heterologous; Tumor Cells, Cultured | 2004 |
Imaging of canine cancers with 18F-2-fluoro-2-deoxy-D-glucose (FDG) suggests further applications for cancer imaging in man.
Topics: Animals; Deoxy Sugars; Deoxyglucose; Dog Diseases; Dogs; Female; Fluorine; Fluorodeoxyglucose F18; Male; Mammary Glands, Animal; Neoplasms; Osteosarcoma; Radioisotopes; Radionuclide Imaging | 1984 |
Hexose transport in hybrids between malignant and normal cells.
Topics: Animals; Biological Transport, Active; Deoxy Sugars; Deoxyglucose; Fibroblasts; Fibrosarcoma; Hexoses; Hybridomas; Kinetics; Lymphocytes; Melanoma; Mice; Mice, Inbred C57BL; Neoplasms, Experimental; Osteosarcoma | 1981 |
Modulation of glucose transport by parathyroid hormone and insulin in UMR 106-01, a clonal rat osteogenic sarcoma cell line.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Animals; Biological Transport; Bone Neoplasms; Clone Cells; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Deoxyglucose; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Glucose; Glucose Transporter Type 1; Insulin; Kinetics; Monosaccharide Transport Proteins; Neoplasm Proteins; Organ Specificity; Osteosarcoma; Parathyroid Hormone; Peptide Fragments; Rats; RNA, Messenger; RNA, Neoplasm; Signal Transduction; Teriparatide; Tumor Cells, Cultured | 1995 |
Regulatory interaction of ATP Na+ and Cl- in the turnover cycle of the NaK2Cl cotransporter.
Topics: Adenosine Triphosphate; Animals; Antimycin A; Bumetanide; Carrier Proteins; Chlorides; Deoxyglucose; Dose-Response Relationship, Drug; Humans; Osteosarcoma; Ouabain; Potassium; Rubidium Radioisotopes; Sodium; Sodium-Potassium-Chloride Symporters; Sodium-Potassium-Exchanging ATPase; Tumor Cells, Cultured | 1993 |
Metabolic and transcriptional changes in osteosarcoma cells treated with chemotherapeutic drugs.
Topics: Animals; Antineoplastic Agents; Bone Neoplasms; Cisplatin; Deoxyglucose; Flow Cytometry; Fluorodeoxyglucose F18; Lung Neoplasms; Organophosphorus Compounds; Organoplatinum Compounds; Osteosarcoma; Rats; Thymidine; Transcription, Genetic | 1994 |
Hypersensitization of tumor cells to glycolytic inhibitors.
Topics: Anaerobiosis; Antimycin A; Culture Media; Deoxyglucose; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Enzyme Inhibitors; Glucose; Glycolysis; Growth Inhibitors; Humans; Lactic Acid; Oligomycins; Osteosarcoma; Oxamic Acid; Oxidative Phosphorylation; Rhodamine 123; Rotenone; Tumor Cells, Cultured; Uncoupling Agents | 2001 |
Simultaneous recording of cell volume changes and intracellular pH or Ca2+ concentration in single osteosarcoma cells UMR-106-01.
Topics: Adenosine Triphosphate; Amiloride; Animals; Calcium; Carrier Proteins; Cell Line; Chlorides; Deoxyglucose; Fluorescent Dyes; Hydrogen-Ion Concentration; Kinetics; Microscopy, Fluorescence; Osteosarcoma; Potassium; Rats; Sodium; Sodium-Hydrogen Exchangers; Tumor Cells, Cultured; Valinomycin | 1992 |
Demonstration of insulin receptors and modulation of alkaline phosphatase activity by insulin in rat osteoblastic cells.
Topics: Affinity Labels; Alkaline Phosphatase; Aminoisobutyric Acids; Animals; Binding, Competitive; Cell Line; Chloroquine; Deoxyglucose; Insulin; Kinetics; Osteoblasts; Osteosarcoma; Photochemistry; Proinsulin; Rats; Receptor, Insulin | 1986 |